Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Dec;55(12):1007–1015. doi: 10.1136/thorax.55.12.1007

Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack

J Kolbe 1, W Fergusson 1, M Vamos 1, J Garrett 1
PMCID: PMC1745649  PMID: 11083885

Abstract

BACKGROUND—Severe life threatening asthma (SLTA) is important in its own right and as a proxy for asthma death. In order to target hospital based intervention strategies to those most likely to benefit, risk factors for SLTA among those admitted to hospital need to be identified. A case-control study was undertaken to determine whether, in comparison with patients admitted to hospital with acute asthma, those with SLTA have different sociodemographic and clinical characteristics, evidence of inadequate ongoing medical care, barriers to health care, or deficiencies in management of the acute attack.
METHODS—Seventy seven patients with SLTA were admitted to an intensive care unit (pH 7.17 (0.15), PaCO2 10.7 (5.0) kPa) and 239 matched controls (by date of index attack) with acute asthma were admitted to general medical wards. A questionnaire was administered 24-48 hours after admission.
RESULTS—The risk of SLTA in comparison with other patients admitted with acute asthma increased with age (odds ratio (OR) 1.04/year, 95% CI 1.01 to 1.07) and was less for women (OR 0.36, 95% CI 0.20to 0.68). These variables were controlled for in all subsequent analyses. There were no differences in other sociodemographic features. Cases were more likely to have experienced a previous SLTA (OR 2.04, 95% CI 1.20 to 3.45) and to have had a hospital admission in the last year (OR 1.86, 95% CI 1.09 to 3.18). There were no differences between cases and controls in terms of indicators of quality of ongoing asthma specific medical care, nor was there evidence of disproportionate barriers to health care. During the index attack cases had more severe asthma at the time of presentation, were less likely to have presented to general practitioners, and were more likely to have called an ambulance or presented to an emergency department. In terms of pharmacological management, those with SLTA were more likely to have been using oral theophylline (OR 2.14, 95% CI 1.35 to 3.68) and less likely to have been using inhaled corticosteroids in the two weeks before the index attack (OR 0.69, 95% CI 0.47 to 0.99). While there was no difference in self-management knowledge or behaviour scores, those with SLTA were more likely to have inappropriately used oral corticosteroids during the acute attack (OR 2.09, 95% CI 1.02 to 4.47).
CONCLUSIONS—In comparison with those admitted to hospital with acute severe asthma, patients with SLTA were indistinguishable on sociodemographic criteria (apart from male predominance), were more likely to have had a previous SLTA or hospital admission in the previous year, had similar quality ongoing asthma care, had no evidence of increased physical, economic or other barriers to health care, but had demonstrable deficiencies in the management of the acute index attack. Educational interventions, while not losing sight of the need for good quality ongoing care, should focus on providing individual patients with better advice on self-management of acute exacerbations.



Full Text

The Full Text of this article is available as a PDF (159.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Jonsson B., Klim J. B. The costs of asthma. Eur Respir J. 1996 Apr;9(4):636–642. doi: 10.1183/09031936.96.09040636. [DOI] [PubMed] [Google Scholar]
  2. Beaglehole R., Jackson R., Sears M., Rea H. Asthma mortality in New Zealand: a review with some policy implications. N Z Med J. 1987 Apr 22;100(822):231–234. [PubMed] [Google Scholar]
  3. Beasley R., Pearce N., Crane J. Use of near fatal asthma for investigating asthma deaths. Thorax. 1993 Nov;48(11):1093–1094. doi: 10.1136/thx.48.11.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blanc P. Occupational asthma in a national disability survey. Chest. 1987 Oct;92(4):613–617. doi: 10.1378/chest.92.4.613. [DOI] [PubMed] [Google Scholar]
  5. Burgess C., Pearce N., Thiruchelvam R., Wilkinson R., Linaker C., Woodman K., Crane J., Beasley R. Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J. 1994 Mar;7(3):498–503. doi: 10.1183/09031936.94.07030498. [DOI] [PubMed] [Google Scholar]
  6. Campbell D. A., Luke C. G., McLennan G., Coates J. R., Frith P. A., Gluyas P. A., Latimer K. M., Martin A. J., Ruffin R. E., Yellowlees P. M. Near-fatal asthma in South Australia: descriptive features and medication use. Aust N Z J Med. 1996 Jun;26(3):356–362. doi: 10.1111/j.1445-5994.1996.tb01922.x. [DOI] [PubMed] [Google Scholar]
  7. Cochrane G. M., Clark J. H. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971. Thorax. 1975 Jun;30(3):300–305. doi: 10.1136/thx.30.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crane J., Lewis S., Slater T., Crossland L., Robson B., D'Souza W., Pearce N., Town G. I., Garrett J., Armstrong R. The self reported prevalence of asthma symptoms amongst adult New Zealanders. N Z Med J. 1994 Oct 26;107(988):417–421. [PubMed] [Google Scholar]
  9. Dirks J. F., Horton D. J., Kinsman R. A., Fross K. H., Jones N. F. Patient and physician characteristics influencing medical decisions in asthma. J Asthma Res. 1978 Jul;15(4):171–178. doi: 10.3109/02770907809106603. [DOI] [PubMed] [Google Scholar]
  10. Dirks J. F., Horton D. J., Kinsman R. A., Fross K. H., Jones N. F. Patient and physician characteristics influencing medical decisions in asthma. J Asthma Res. 1978 Jul;15(4):171–178. doi: 10.3109/02770907809106603. [DOI] [PubMed] [Google Scholar]
  11. Dirks J. F., Kinsman R. A., Staudenmayer H., Kleiger J. H. Panic-fear in asthma. Symptomatology as an index of signal anxiety and personality as an index of ego resources. J Nerv Ment Dis. 1979 Oct;167(10):615–619. [PubMed] [Google Scholar]
  12. Donahue J. G., Weiss S. T., Livingston J. M., Goetsch M. A., Greineder D. K., Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997 Mar 19;277(11):887–891. [PubMed] [Google Scholar]
  13. Ernst P., Spitzer W. O., Suissa S., Cockcroft D., Habbick B., Horwitz R. I., Boivin J. F., McNutt M., Buist A. S. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA. 1992 Dec 23;268(24):3462–3464. [PubMed] [Google Scholar]
  14. Garrett J. E., Lanes S. F., Kolbe J., Rea H. H. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Thorax. 1996 Nov;51(11):1093–1099. doi: 10.1136/thx.51.11.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Garrett J., Kolbe J., Richards G., Whitlock T., Rea H. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax. 1995 Mar;50(3):303–311. doi: 10.1136/thx.50.3.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guidelines for management of asthma in adults: I--Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ. 1990 Sep 29;301(6753):651–653. doi: 10.1136/bmj.301.6753.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Guidelines for management of asthma in adults: II--Acute severe asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ. 1990 Oct 6;301(6755):797–800. doi: 10.1136/bmj.301.6755.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  19. Jones A. P., Bentham G. Health service accessibility and deaths from asthma in 401 local authority districts in England and Wales, 1988-92. Thorax. 1997 Mar;52(3):218–222. doi: 10.1136/thx.52.3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Juniper E. F., Kline P. A., Vanzieleghem M. A., Ramsdale E. H., O'Byrne P. M., Hargreave F. E. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990 Oct;142(4):832–836. doi: 10.1164/ajrccm/142.4.832. [DOI] [PubMed] [Google Scholar]
  21. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  22. Kolbe J. Asthma education, action plans, psychosocial issues and adherence. Can Respir J. 1999 May-Jun;6(3):273–280. doi: 10.1155/1999/413547. [DOI] [PubMed] [Google Scholar]
  23. Kolbe J., Fergusson W., Garrett J. Rapid onset asthma: a severe but uncommon manifestation. Thorax. 1998 Apr;53(4):241–247. doi: 10.1136/thx.53.4.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kolbe J., Vamos M., Fergusson W., Elkind G. Determinants of management errors in acute severe asthma. Thorax. 1998 Jan;53(1):14–20. doi: 10.1136/thx.53.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kolbe J., Vamos M., Fergusson W., Elkind G., Garrett J. Differential influences on asthma self-management knowledge and self-management behavior in acute severe asthma. Chest. 1996 Dec;110(6):1463–1468. doi: 10.1378/chest.110.6.1463. [DOI] [PubMed] [Google Scholar]
  26. Kolbe J., Vamos M., Fergusson W. Socio-economic disadvantage, quality of medical care and admission for acute severe asthma. Aust N Z J Med. 1997 Jun;27(3):294–300. doi: 10.1111/j.1445-5994.1997.tb01981.x. [DOI] [PubMed] [Google Scholar]
  27. Kolbe J., Vamos M., James F., Elkind G., Garrett J. Assessment of practical knowledge of self-management of acute asthma. Chest. 1996 Jan;109(1):86–90. doi: 10.1378/chest.109.1.86. [DOI] [PubMed] [Google Scholar]
  28. Laitinen L. A., Laitinen A., Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992 Jul;90(1):32–42. doi: 10.1016/s0091-6749(06)80008-4. [DOI] [PubMed] [Google Scholar]
  29. Macdonald J. B., Seaton A., Williams D. A. Asthma deaths in Cardiff 1963-74: 90 deaths outside hospital. Br Med J. 1976 Jun 19;1(6024):1493–1495. doi: 10.1136/bmj.1.6024.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Marquette C. H., Saulnier F., Leroy O., Wallaert B., Chopin C., Demarcq J. M., Durocher A., Tonnel A. B. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis. 1992 Jul;146(1):76–81. doi: 10.1164/ajrccm/146.1.76. [DOI] [PubMed] [Google Scholar]
  31. Miller B. D., Strunk R. C. Circumstances surrounding the deaths of children due to asthma. A case-control study. Am J Dis Child. 1989 Nov;143(11):1294–1299. doi: 10.1001/archpedi.1989.02150230052022. [DOI] [PubMed] [Google Scholar]
  32. Ormerod L. P., Stableforth D. E. Asthma mortality in Birmingham 1975-7: 53 deaths. Br Med J. 1980 Mar 8;280(6215):687–690. doi: 10.1136/bmj.280.6215.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Poole P. J., Bagg B., Brodie S. M., Black P. N. Characteristics of patients admitted to hospital with chronic obstructive pulmonary disease. N Z Med J. 1997 Jul 25;110(1048):272–275. [PubMed] [Google Scholar]
  34. Rea H. H., Garrett J. E., Lanes S. F., Birmann B. M., Kolbe J. The association between asthma drugs and severe life-threatening attacks. Chest. 1996 Dec;110(6):1446–1451. doi: 10.1378/chest.110.6.1446. [DOI] [PubMed] [Google Scholar]
  35. Rea H. H., Garrett J. E., Mulder J., Chapman K. R., White J. G., Rebuck A. S. Emergency room care of asthmatics: a comparison between Auckland and Toronto. Ann Allergy. 1991 Jan;66(1):48–52. [PubMed] [Google Scholar]
  36. Rea H. H., Scragg R., Jackson R., Beaglehole R., Fenwick J., Sutherland D. C. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833–839. doi: 10.1136/thx.41.11.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Richards G. N., Kolbe J., Fenwick J., Rea H. H. Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths. Thorax. 1993 Nov;48(11):1105–1109. doi: 10.1136/thx.48.11.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ryan G., Musk A. W., Perera D. M., Stock H., Knight J. L., Hobbs M. S. Risk factors for death in patients admitted to hospital with asthma: a follow-up study. Aust N Z J Med. 1991 Oct;21(5):681–685. doi: 10.1111/j.1445-5994.1991.tb01370.x. [DOI] [PubMed] [Google Scholar]
  39. Sears M. R., Rea H. H., Beaglehole R. Asthma mortality: a review of recent experience in New Zealand. J Allergy Clin Immunol. 1987 Sep;80(3 Pt 1):319–325. doi: 10.1016/0091-6749(87)90038-8. [DOI] [PubMed] [Google Scholar]
  40. Sears M. R., Rea H. H., Beaglehole R., Gillies A. J., Holst P. E., O'Donnell T. V., Rothwell R. P., Sutherland D. C. Asthma mortality in New Zealand: a two year national study. N Z Med J. 1985 Apr 24;98(777):271–275. [PubMed] [Google Scholar]
  41. Sears M. R., Taylor D. R., Print C. G., Lake D. C., Herbison G. P., Flannery E. M. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma. Chest. 1992 Dec;102(6):1709–1715. doi: 10.1378/chest.102.6.1709. [DOI] [PubMed] [Google Scholar]
  42. Sibbald B., Collier J., D'Souza M. Questionnaire assessment of patients' attitudes and beliefs about asthma. Fam Pract. 1986 Mar;3(1):37–41. doi: 10.1093/fampra/3.1.37. [DOI] [PubMed] [Google Scholar]
  43. Sont J. K., Han J., van Krieken J. M., Evertse C. E., Hooijer R., Willems L. N., Sterk P. J. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax. 1996 May;51(5):496–502. doi: 10.1136/thx.51.5.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  45. Staudenmayer H., Kinsman R. A., Dirks J. F., Spector S. L., Wangaard C. Medical outcome in asthmatic patients: effects of airways hyperreactivity and symptom-focused anxiety. Psychosom Med. 1979 Mar;41(2):109–118. doi: 10.1097/00006842-197903000-00004. [DOI] [PubMed] [Google Scholar]
  46. Trigg C. J., Manolitsas N. D., Wang J., Calderón M. A., McAulay A., Jordan S. E., Herdman M. J., Jhalli N., Duddle J. M., Hamilton S. A. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med. 1994 Jul;150(1):17–22. doi: 10.1164/ajrccm.150.1.8025745. [DOI] [PubMed] [Google Scholar]
  47. Turner M. O., Noertjojo K., Vedal S., Bai T., Crump S., Fitzgerald J. M. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1804–1809. doi: 10.1164/ajrccm.157.6.9708092. [DOI] [PubMed] [Google Scholar]
  48. Vamos M. J., James F. R., Kolbe J. Cultural issues facing medical research in New Zealand: short report of an asthma pilot study. N Z Med J. 1994 Apr 13;107(975):132–133. [PubMed] [Google Scholar]
  49. Wareham N. J., Harrison B. D., Jenkins P. F., Nicholls J., Stableforth D. E. A district confidential enquiry into deaths due to asthma. Thorax. 1993 Nov;48(11):1117–1120. doi: 10.1136/thx.48.11.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wasserfallen J. B., Schaller M. D., Feihl F., Perret C. H. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis. 1990 Jul;142(1):108–111. doi: 10.1164/ajrccm/142.1.108. [DOI] [PubMed] [Google Scholar]
  51. Westerman D. E., Benatar S. R., Potgieter P. D., Ferguson A. D. Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus. Am J Med. 1979 Apr;66(4):565–572. doi: 10.1016/0002-9343(79)91165-3. [DOI] [PubMed] [Google Scholar]
  52. Westerman D. E., Benatar S. R., Potgieter P. D., Ferguson A. D. Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus. Am J Med. 1979 Apr;66(4):565–572. doi: 10.1016/0002-9343(79)91165-3. [DOI] [PubMed] [Google Scholar]
  53. Woolcock A. J., Yan K., Salome C. M. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin Allergy. 1988 Mar;18(2):165–176. doi: 10.1111/j.1365-2222.1988.tb02856.x. [DOI] [PubMed] [Google Scholar]
  54. Woolcock A., Rubinfeld A. R., Seale J. P., Landau L. L., Antic R., Mitchell C., Rea H. H., Zimmerman P. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989 Dec 4;151(11-12):650–653. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES